Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience
Abstract
:Simple Summary
Abstract
1. Introduction
- -
- assessment of the pancreatic and adrenal manifestations of multiple endocrine neoplasia type 1 (MEN1);
- -
- localization of insulinoma including planning adequate surgical strategy;
- -
- detection and localization or even exclusion of aldosterone-producing adenomas (APA, Conn’s adenomas) and defining adequate therapeutic strategy.
2. Multiple Endocrine Neoplasia Type 1
3. Insulinoma
4. Primary Aldosteronism
- Positive screening/case finding test for PA, i.e., positive aldosterone/renin ratio (A/R) [45], and high serum/plasma aldosterone concentration as suggested by Young [53]; or in early times, in which the A/R had not been established, an elevated aldosterone level with renin concentration in the low normal range was accepted. If the analysis had been performed in our laboratory (supine blood sampling after 30 min bed rest), cutoff for A/R had been defined as 3.8, and high aldosterone serum concentration as ≥ 15.0 ng/dL [53]. If aldosterone and/or renin analysis had not been performed in our laboratory, and the units used had not matched with our methods, cutoffs referring to the respective methods were used.
- Diagnosis of arterial hypertension, i.e., documented systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg [54], or prevalent antihypertensive medication before EUS imaging.
4.1. Saline Infusion Test (SIT)
4.2. Captopril Challenge Test (CCT)
4.3. Aldosterone and Aldosterone Metabolites in 24 h Urine Sampling
4.4. Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Conventional Sonography (CS)
4.5. Selective Adrenal Vein Sampling (AVS)
4.6. Posture Stimulation Test (PST)
4.7. Endoscopic Ultrasound (EUS)
4.8. Definition of Aldosterone-Producing Adenoma (APA)
4.9. Data Analysis
- -
- diagnosis of adrenal adenoma by histopathology;
- -
- preoperatively serum or plasma aldosterone highly normal or above the normal range as described above with
- ○
- elevated A/R;
- ○
- or serum or plasma renin below the normal range or in the very low normal range (in early times when A/R has not been applied).
- -
- ≥50% of the following criteria as available needed to be fulfilled:
- ○
- positive SIT or CCT;
- ○
- elevated aldosterone or aldosterone metabolites in 24 h urine sampling;
- ○
- positive lateralization in AVS;
- ○
- documented postsurgical clinical improvement following suggestions by Vorselaars et al. [61], for this study defined by postoperative arterial normotension without antihypertensive treatment or reduced antihypertensive treatment;
- ○
- postsurgical normalization of aldosterone and renin in serum or plasma.
4.9.1. Major Study Endpoint
4.9.2. Minor Study Endpoints
5. Results
6. Discussion
7. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kann, P.; Bittinger, F.; Hengstermann, C.; Engelbach, M.; Beyer, J. Endosonography of the adrenal glands: Normal size—Pathological findings. Exp. Clin. Endocrinol. Diabetes 1998, 106, 123–129. [Google Scholar] [CrossRef] [PubMed]
- Collienne, M.; Timmesfeld, N.; Bergmann, S.R.; Goebel, J.; Kann, P.H. Adrenal incidentaloma and subclinical Cushing’s syndrome: A longitudinal follow-up study by endoscopic ultrasound. Ultraschall Med. 2017, 38, 411–419. [Google Scholar] [CrossRef] [PubMed]
- Fassnacht, M.; Arlt, W.; Bancos, I.; Dralle, H.; Newell-Price, J.; Sahdev, A.; Tabarin, A.; Terzolo, M.; Tsagarakis, S.; Dekkers, O.M. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2016, 175, G1–G34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kann, P.H.; Wirkus, B.; Behr, T.; Klose, K.-J.; Meyer, S. Endosonographic imaging of benign and malignant pheochromocytomas. J. Clin. Endocrinol. Metab. 2004, 89, 1694–1697. [Google Scholar] [CrossRef] [Green Version]
- Meyer, S.; Kann, B.; von Mach, M.A.; Brück, C.; Ivan, D.; Köhler, U.; Behr, T.; Klose, K.-J.; Pfützner, A.; Forst, T.; et al. Die Rolle der Endosonographie in der Detektion und Klassifikation des Phäochromocytoms. Nieren Hochdruck. 2005, 34, 445–454. [Google Scholar] [CrossRef]
- Meyer, S.; von Mach, M.-A.; Ivan, D.; Schaefer, S.; Habbe, N.; Kann, B.; Kann, P.H. Color-coded duplex endoscopic ultrasound (CD-EUS) of the adrenals. J. Endocrinol. Investig. 2008, 31, 882–887. [Google Scholar] [CrossRef]
- Özkul, N.; Kann, P.H. Pheochromocytoma and adrenocortical carcinoma: Morphological characteristics in endoscopic ultrasound imaging. Ultrasound Int. Open 2021, 7, E64–E70. [Google Scholar] [CrossRef]
- Kann, P.H. The value of endoscopic ultrasound in localizing gastrinoma. Wien. Klin. Wochenschr. 2007, 119, 585–587. [Google Scholar] [CrossRef]
- Rossi, R.E.; Elvevi, A.; Citterio, D.; Coppa, J.; Invernizzi, P.; Mazzaferro, V.; Massironi, S. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J. Gastroenterol. 2021, 27, 5890–5907. [Google Scholar] [CrossRef]
- Underdahl, L.O.; Woolner, L.B.; Black, B.M. Multiple endocrine adenomas: Report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J. Clin. Endocrinol. Metab. 1953, 13, 20–47. [Google Scholar] [CrossRef]
- Wermer, P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 1954, 16, 363–371. [Google Scholar] [CrossRef]
- Chandrasekharappa, S.C.; Guru, S.C.; Manickam, P.; Olufemi, S.E.; Collins, F.S.; Emmert-Buck, M.R.; Debelenko, L.V.; Zhuang, Z.; Lubensky, I.A.; Liotta, L.A.; et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276, 404–407. [Google Scholar] [CrossRef]
- Schussheim, D.H.; Skarulis, M.C.; Agarwal, S.K.; Simonds, W.F.; Burns, A.L.; Spiegel, A.M.; Marx, S.J. Multiple endocrine neoplasia type 1: New clinical and basic findings. Trends Endocrinol. Metab. 2001, 12, 173–178. [Google Scholar] [CrossRef]
- Langer, P.; Cupisti, K.; Bartsch, D.K.; Nies, C.; Goretzki, P.E.; Rothmund, M.; Röher, H.D. Adrenal involvement in multiple endocrine neoplasia type 1. World J. Surg. 2002, 26, 891–896. [Google Scholar] [CrossRef]
- Schaefer, S.; Shipotko, M.; Meyer, S.; Ivan, D.; Klose, K.J.; Waldmann, J.; Langer, P.; Kann, P.H. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: An endoscopic ultrasound imaging study. Eur. J. Endocrinol. 2008, 158, 699–704. [Google Scholar] [CrossRef] [Green Version]
- Kann, P.H.; Balakina, E.; Ivan, D.; Bartsch, D.K.; Meyer, S.; Klose, K.-J.; Behr, T.; Langer, P. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: An endoscopic ultrasound imaging study. Endocr.-Relat. Cancer 2006, 13, 1195–1202. [Google Scholar] [CrossRef] [Green Version]
- Kann, P.H. Endoscopic Ultrasound in Endocrinology: Imaging of the adrenals and the endocrine pancreas. Front. Horm. Res. 2016, 45, 46–54. [Google Scholar]
- Kann, P.; Bittinger, F.; Engelbach, M.; Bohner, S.; Weis, A.; Hengstermann, C.; Beyer, J. Endosonography of insulin-secreting and clinically non-functioning neuroendocrine tumors of the pancreas: Criteria for benignancy and malignancy. Eur. J. Med. Res. 2001, 6, 385–390. [Google Scholar]
- Langer, P.; Kann, P.H.; Richter, G.; Fendrich, V.; Nies, C.; Rothmund, M.; Bartsch, D.K. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumours (PETs) in patients with multiple endocrine neoplasia type 1 (MEN1). World. J. Surg. 2004, 28, 1317–1322. [Google Scholar] [CrossRef]
- Kann, P.H. Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic endocrine tumors? Rev. Endocr. Metab. Disord. 2018, 19, 133–137. [Google Scholar] [CrossRef]
- Waldmann, J.; Habbe, N.; Fendrich, V.; Slater, E.P.; Kann, P.H.; Rothmund, M.; Langer, P. Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: A case report. J. Med. Case Rep. 2008, 2, 354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Waldmann, J.; Fendrich, V.; Habbe, N.; Bartsch, D.K.; Slater, E.P.; Kann, P.H.; Rothmund, M.; Langer, P. Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): A critical analysis of its value. World. J. Surg. 2009, 33, 1208–1218. [Google Scholar] [CrossRef] [PubMed]
- Kann, P.H.; Kann, B.; Fassbender, W.J.; Forst, T.; Bartsch, D.K.; Langer, P. Small neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1): Least significant change of tumor diameter as determined by endoscopic ultrasound (EUS) imaging. Exp. Clin. Endocrinol. Diabetes 2006, 114, 361–365. [Google Scholar] [CrossRef] [PubMed]
- Gaujoux, S.; Partelli, S.; Maire, F.; D’Onofrio, M.; Larroque, B.; Tamburrino, D.; Sauvanet, A.; Falconi, M.; Ruszniewski, P. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J. Clin. Endocrinol. Metab. 2013, 98, 4784–4789. [Google Scholar] [CrossRef] [Green Version]
- Pieterman, C.R.C.; de Laat, J.M.; Twisk, J.W.R.; van Leeuwaarde, R.S.; de Herder, W.W.; Dreijerink, K.M.A.; Hermus, A.R.M.M.; Dekkers, O.M.; van der Horst-Schrivers, A.N.A.; Drent, M.L.; et al. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1—Results from the Dutch MEN1 Study Group. J. Clin. Endocrinol. Metab. 2017, 102, 3795–3805. [Google Scholar] [CrossRef] [Green Version]
- Kappelle, W.F.; Valk, G.D.; Leenders, M.; Moons, L.M.; Bogte, A.; Siersema, P.D.; Vleggaar, F.P. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: Results from an endoscopic ultrasound based cohort study. Endoscopy 2017, 49, 27–34. [Google Scholar] [CrossRef]
- Triponez, F.; Sadowski, S.M.; Pattou, F.; Cardot-Bauters, C.; Mirallié, E.; Le Bras, M.; Sebag, F.; Niccoli, P.; Deguelte, S.; Cadiot, G.; et al. Long-term follow-up of MEN1 patients who do not have initial surgery for small ≤2 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE study: Association Francophone de Chirurgie Endocrinienne & Groupe d’Etude des Tumeurs Endocrines. Ann. Surg. 2018, 268, 158–164. [Google Scholar]
- Kann, P.H.; Scheunemann, A.; Adelmeyer, J.; Bergmann, S.; Goebel, J.N.; Bartsch, D.K.; Holzer, K.; Albers, M.B.; Manoharan, J.; Scheunemann, L.M. Regional growth velocity and incidence of pancreatic neuroendocrine neoplasias in multiple endocrine neoplasia type 1. Pancreas 2023, 52. in press. [Google Scholar] [CrossRef]
- Kann, P.H.; Scheunemann, A.; Dorzweiler, P.; Adelmeyer, J.; Bergmann, S.; Goebel, J.N.; Mann, V.; Bartsch, D.K.; Holzer, K.; Albers, M.B.; et al. Pancreatic neuroendocrine neoplasias in multiple endocrine neoplasia type 1 are predominantly located in the dorsal anlage: An endoscopic ultrasound study. Pancreas 2021, 50, 1169–1172. [Google Scholar] [CrossRef]
- Wang, X.; Tan, C.L.; Song, H.Y.; Yao, Q.; Liu, X.B. Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms. World J. Gastroenterol. 2017, 23, 6457–6466. [Google Scholar] [CrossRef]
- Waldmann, J.; Bartsch, D.K.; Kann, P.H.; Fendrich, V.; Rothmund, M.; Langer, P. Adrenal involvement in multiple endocrine neoplasia type 1: Results of 7 years prospective screening. Langenbeck’s Arch. Surg. 2007, 392, 437–443. [Google Scholar] [CrossRef]
- Kann, P.H.; Schaefer, S. Neuroendokrine Tumoren des Pankreas: Insulinome—Klinische Symptomatik und Diagnostik. In Praxis der Viszeralchirurgie—Endokrine Chirurgie; Siewert, J.R., Rothmund, M., Schumpelick, V., Eds.; Springer Medizin: Berlin/Heidelberg, Germany, 2007; pp. 403–407. [Google Scholar]
- Cryer, P.E.; Axelrod, L.; Grossman, A.B.; Heller, S.R.; Montori, V.M.; Seaquist, E.R.; Service, F.J. Endocrine Society. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2009, 94, 709–728. [Google Scholar] [CrossRef] [Green Version]
- Guettier, J.M.; Lungu, A.; Goodling, A.; Cochran, C.; Gorden, P. The role of proinsulin and insulin in the diagnosis of insulinoma: A critical evaluation of the Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2013, 98, 4752–4758. [Google Scholar] [CrossRef] [Green Version]
- Kann, P.H.; Moll, R.; Bartsch, D.K.; Pfützner, A.; Forst, T.; Tamagno, G.; Goebel, J.N.; Fourkiotis, V.; Bergmann, S.R.; Collienne, M. Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients. Endocrine 2017, 56, 158–163. [Google Scholar] [CrossRef]
- Kann, P.H.; Rothmund, M.; Zielke, A. Endoscopic ultrasound imaging of insulinomas: Limitations and clinical relevance. Exp. Clin. Endocrinol. Diabetes 2005, 113, 471–474. [Google Scholar] [CrossRef]
- Kann, P.H.; Ivan, D.; Pfützner, A.; Forst, T.; Langer, P.; Schaefer, S. Preoperative diagnosis of insulinoma: Low body mass index, young age and female gender are associated with negative imaging by endoscopic ultrasound. Eur. J. Endocrinol. 2007, 157, 209–213. [Google Scholar] [CrossRef] [Green Version]
- Andreassen, M.; Ilett, E.; Wiese, D.; Slater, E.P.; Klose, M.; Hansen, C.P.; Gercke, N.; Langer, S.W.; Kjaer, A.; Maurer, E.; et al. Surgical management, pre-operative tumor localization and histopathology of 80 patients operated for insulinoma. J. Clin. Endocrinol. Metab. 2019, 104, 6129–6138. [Google Scholar] [CrossRef]
- Wiese, D.; Humburg, F.; Kann, P.H.; Rinke, A.; Luster, M.; Mahnken, A.; Bartsch, D.K. Changes in diagnostic nd operative treatment of insulinoma over two decades. Langenbeck’s Arch. Surg. 2023, 408, 255. [Google Scholar] [CrossRef]
- Kann, P.H.; Wirkus, B.; Keth, A.; Goitom, K. Pitfalls in endosonographic imaging of suspected insulinomas: Pancreatic nodules of unknown dignity. Eur. J. Endocrinol. 2003, 148, 531–534. [Google Scholar] [CrossRef] [Green Version]
- Gkolfakis, P.; Crinò, S.F.; Tziatzios, G.; Ramai, D.; Papaefthymiou, A.; Papanikolaou, I.S.; Triantafyllou, K.; Arvanitakis, M.; Lisotti, A.; Fusaroli, P.; et al. Comparative diagnostic performance of end-cutting fine-needle biopsy needles for EUS tissue sampling of solid pancreatic masses: A network meta-analysis. Gastrointest. Endosc. 2022, 95, 1067–1077. [Google Scholar] [CrossRef]
- Adelmeyer, J.; Göbel, F.; Kann, P.H. Is the size of insulinoma predicitive for its endocrine behaviour? An endoscopic ultrasound study. Exp. Clin. Endocrinol. Diabetes 2022, 130, 687–692. [Google Scholar] [PubMed]
- Crinò, S.F.; Napoleon, B.; Facciorusso, A.; Lakhtakia, S.; Borbath, I.; Caillol, F.; Pham, K.D.-C.; Rizzatti, G.; Forti, E.; Palazzo, L.; et al. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma. Clin. Gastroentrol. Hepatol. 2023. in print. [Google Scholar] [CrossRef] [PubMed]
- Conn, J.W. Diagnosis of normokalemic primary aldosteronism, a new form of curable hypertension. Science 1967, 158, 525–526. [Google Scholar] [CrossRef] [PubMed]
- Funder, J.W.; Carey, R.M.; Mantero, F.; Murad, M.H.; Reincke, M.; Shibata, H.; Stowasser, M.; Young, W.F., Jr. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2016, 101, 1889–1916. [Google Scholar] [CrossRef] [PubMed]
- Mulatero, P.; Bertello, C.; Rossato, D.; Mengozzi, G.; Milan, A.; Garrone, C.; Giraudo, G.; Passarino, G.; Garabello, D.; Verhovez, A.; et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J. Clin. Endocrinol. Metab. 2008, 93, 1366–1371. [Google Scholar] [CrossRef]
- Vonend, O.; Ockenfels, N.; Gao, X.; Allolio, B.; Lang, K.; Mai, K.; Quack, I.; Saleh, A.; Degenhart, C.; Seufert, J.; et al. Adrenal venous sampling: Evaluation of the German Conn’s registry. Hypertension 2011, 57, 990–995. [Google Scholar] [CrossRef] [Green Version]
- Dekkers, T.; Prejbisz, A.; Schultze Kool, L.J.; Groenewoud, H.J.M.M.; Velema, M.; Spiering, W.; Kołodziejczyk-Kruk, S.; Arntz, M.; Kądziela, J.; Langenhuijsen, J.F. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016, 4, 739–746. [Google Scholar] [CrossRef]
- Kann, P.H. Endoscopic ultrasound imaging of the adrenals. Endoscopy 2005, 37, 244–253. [Google Scholar] [CrossRef]
- Kann, P.H.; Meyer, S.; Zielke, A.; Langer, P.; Ivan, D. Die neue Rolle der Endosonographie in der Endokrinologie: Bildgebung der Nebennieren und des endokrinen Pankreas. Dtsch. Med. Wochenschr. 2006, 131, 567–572. [Google Scholar] [CrossRef]
- Roggenland, D.; Schneider, S.; Klein, H.H.; Kann, P.H. Endosonography—An additional diagnostic possibility in the differentiation between the two common types of primary hyperaldosteronism. Med. Klin. 2006, 101, 65–68. [Google Scholar] [CrossRef]
- Kann, P.H.; Goebel, J.N.; Adelmeyer, J.; Bergmann, S.; Mann, V.; Bartsch, D.K.; Holzer, K.; Ramaswamy, A.; Mahnken, A.H.; Leonhardt, A. Endoscopic ultrasound of the adrenals in primary aldosteronism. Clin. Surg. 2021, 6, 3097. [Google Scholar]
- Young, W.F. Primary aldosteronism: Renaissance of a syndrome. Clin. Endocrinol. 2007, 66, 607–618. [Google Scholar] [CrossRef] [PubMed]
- Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak, A.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018, 39, 3021–3104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mönig, H.; Kern, W.; Partsch, C.J.; Sippel, W.G.; Lehnert, H. Dynamische Funktionstests in der Endokrinologie. In Deutsche Gesellschaft für Endokrinologie; Lehnert, H., Ed.; Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel; Georg Thieme Verlag: Stuttgart, Germany; New York, NY, USA, 2009; p. 514. [Google Scholar]
- Giachetti, G.; Ronconi, V.; Lucarelli, G.; Boscaro, M.; Mantero, F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: Need for a standardized protocol. J. Hypertens. 2006, 24, 737–745. [Google Scholar] [CrossRef] [PubMed]
- Rossi, G.P.; Belfiore, A.; Bernini, G.; Desideri, G.; Fabris, B.; Ferri, C.; Giacchetti, G.; Letizia, C.; Maccario, M.; Mallamaci, F.; et al. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J. Hypertens. 2007, 25, 1433–4142. [Google Scholar] [CrossRef] [Green Version]
- Mourad, J.J.; Girerd, X.; Milliez, P.; Lopez-Sublet, M.; Lejeune, S.; Safar, M.E. Urinary aldosterone-to-active-renin ratio: A useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am. J. Hypertens. 2008, 21, 742–747. [Google Scholar] [CrossRef] [Green Version]
- Rossi, G.P.; Auchus, R.J.; Brown, M.; Lenders, J.W.; Naruse, M.; Plouin, P.F.; Satoh, F.; Young, W.F., Jr. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014, 63, 151–160. [Google Scholar] [CrossRef]
- Fontes, R.G.; Kater, C.E.; Biglieri, E.G.; Irony, I. Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. Am. J. Hypertens. 1991, 4, 786–791. [Google Scholar] [CrossRef]
- Vorselaars, W.M.C.M.; Nell, S.; Postma, E.L.; Zarnegar, R.; Thurston Drake, F.; Duh, Q.-Y.; Talutis, S.D.; McAneny, D.B.; McManus, C.; Lee, J.A.; et al. Clinical outcomes after unilateral adrenalectomy for primary aldosteronism. JAMA Surg. 2019, 154, e185842. [Google Scholar] [CrossRef]
- Sun, N.; Meyer, L.S.; Feuchtinger AKunzke, T.; Knösel, T.; Reincke, M.; Walch, A.; Williams, T.A. Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism. Hypertension 2020, 75, 634–644. [Google Scholar] [CrossRef]
Multiple Endocrine Neoplasia Type 1 | Detection of small tumors from 1–2 mm in diameter → defining “baseline morphology” of each lesion for follow-up. Precise assessment of tumor growth velocity (least significant change < 20% even in very small tumors). Detection of suspicious tumor morphology, morphological changes in follow-up. Detection of atypically fast growing tumors. Planning of surgical intervention:
|
Insulinoma | Localization of a pancreatic lesion typical of an insulinoma:
Planning of surgical intervention:
|
Primary Aldosteronism (Conn’s Adenoma) | Identification of an adrenal lesion with typical morphological features of an aldosteronoma. Defining the remaining parts of the ipsilateral and the contralateral adrenal as morphologically inconspicuous/normal. Planning of surgical intervention: selective adenomectomy possible? |
EUS | 89% | 39/44 | in four cases bilateral adenomas detected |
CT | 81% | 21/26 | |
MRT | 76% | 19/25 | +one falsely located in the contralateral adrenal |
CS | 32% | 6/19 | +two falsely located in the contralateral adrenal |
SAVS | 36% | 5/14 | selectivity index * <2 in 9 cases |
PST | 24% | 5/21 | referring to correct identification APA vs. IHA |
hypoechoic echogenicity | 82% |
largely homogenous echostructure | 72% |
hyperechoic capsular tumor margin | 93% |
termination of medullary echo at tumor margin | 97% |
diameter ≤ 2 cm | 77% |
no/only discrete hyperperfusion (duplex) | 94% |
tumors fulfilling at least four criteria | 98% |
tumors fulfilling at least five criteria | 91% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kann, P.H. Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience. Cancers 2023, 15, 3494. https://doi.org/10.3390/cancers15133494
Kann PH. Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience. Cancers. 2023; 15(13):3494. https://doi.org/10.3390/cancers15133494
Chicago/Turabian StyleKann, Peter Herbert. 2023. "Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience" Cancers 15, no. 13: 3494. https://doi.org/10.3390/cancers15133494
APA StyleKann, P. H. (2023). Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience. Cancers, 15(13), 3494. https://doi.org/10.3390/cancers15133494